Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05320887 · ClinicalTrials.gov registry record · NA
Cigarette and E-cigarette Nicotine Content in an Electronic Tobacco Marketplace (ETM)
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 69
- Enrollment target
NCT05320887: Completed NA study, sponsored by Wake Forest University Health Sciences.
NCT05320887 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 69 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05320887, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 69 participants
- Enrollment target
Study Summary
This study is proposing a four condition Electronic Tobacco Marketplace (ETM) study to determine if banning normal nicotine content (NNC) is sufficient for encouraging smokers to switch to potentially less harmful products or if the availability of higher nicotine and/or flavored alternative products (specifically e-cigarettes) are needed to achieve maximal reductions in smoking.
Primary Outcome
Average number of cigarettes purchased (analyzed as raw data and using derived behavioral economic measures)
Interventions
- OTHER Normal Nicotine Content Vape with all flavor e-liquids
- OTHER Normal nicotine content vape with tobacco e-liquids
- OTHER Low nicotine content vape with all flavor e-liquids
- OTHER Low nicotine content vape with tobacco e-liquids
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2022-07-27 |
| Est. Completion | 2023-08-06 |
| Phase | NA |
What the finished NCT05320887 record still lists
NCT05320887 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 69 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 4 interventions - of which Normal Nicotine Content Vape with all flavor e-liquids is the first listed.
NCT05320887 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05320887 about?
NCT05320887 is a clinical study titled "Cigarette and E-cigarette Nicotine Content in an Electronic Tobacco Marketplace (ETM)". This study is proposing a four condition Electronic Tobacco Marketplace (ETM) study to determine if banning normal nicotine content (NNC) is sufficient for encouraging smokers to switch to potentially less harmful products or if the availability of higher nicotine and/or flavored alternative product...
What is the current status of trial NCT05320887?
This trial is currently completed. It is a NA study. The enrollment target is 69 participants. The study started on 2022-07-27. Estimated completion is 2023-08-06.
What interventions are being tested in trial NCT05320887?
The interventions under investigation include: Normal Nicotine Content Vape with all flavor e-liquids (OTHER), Normal nicotine content vape with tobacco e-liquids (OTHER), Low nicotine content vape with all flavor e-liquids (OTHER), Low nicotine content vape with tobacco e-liquids (OTHER).
Who is sponsoring clinical trial NCT05320887?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05320887's enrollment target sits among peer trials
69 1133rd of 2000 higher than 868 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04020575 · 69 participants · Phase 1
Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)
- NCT04163614 · 69 participants · NA
Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients
- NCT04164641 · 69 participants · NA
Noraxon myoRESEARCH™ Software Gait Analysis Evaluation and Orthotic Gait Correction in Reducing Diabetic Foot Ulceration Or Subsequent Amputation in Patients With a History of a Diabetic Foot Ulceration
- NCT04493372 · 69 participants · NA
Deciphering Preserved Autonomic Function After Spinal Cord Injury
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI